Skip to main content
SpringerLink
Log in

Myositis with immune checkpoint inhibitors in a real-world setting

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Nguyen T, et al. Rheumatic disorders associated with immune checkpoint inhibitors: what about myositis? An analysis of the WHO's adverse drug reactions database. Annals of the Rheumatic Diseases : 17 Feb 2020. Available from: URL: http://dx.doi.org/10.1136/annrheumdis-2020-217018

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Myositis with immune checkpoint inhibitors in a real-world setting. Reactions Weekly 1794, 11 (2020). https://doi.org/10.1007/s40278-020-75807-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-75807-7

Search

Navigation